August 3, 2019
Sponsored by Purolite
Praesto® Jetted A50 is the first protein A resin to meet the future demands in monoclonal antibody (MAb) processing today. It delivers enhanced performance characteristics through Purolite’s patented manufacturing technology: Jetting. This continuous manufacturing process — combined with a novel, alkaline-stable continuous manufacturing process with a novel, alkaline-stable protein A ligand called NGL Impact A™ (supplied by Repligen Corporation) — results in the only bioprocess-scale agarose available with a uniform particle-size distribution. Compared with other resins, Praesto®
Jetted A50 resin delivers superior performance characteristics such as:
Ultrahigh dynamic binding capacity of ~80 g/L
Threefold increase in productivity
Exceptional alkaline stability for hundreds of cycles
Improved flow properties
No fines, decreased resin fouling, and improved lifetime
Up to 40% reduction in buffer volume
80% reduction in resin costs.
Fill out the form below to read the complete technology review now.
You May Also Like
